These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2622809)

  • 1. Eurotherapeutics III. Proceedings of a conference on risk factors in vascular disease: strategies for treatment. Amsterdam, The Netherlands, 29 September to 1 October 1988.
    Postgrad Med J; 1989; 65 Suppl 1():S1-60. PubMed ID: 2622809
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of patients with acute coronary syndromes in the Netherlands in 2000-2001; a comparison with other European countries and with the guidelines].
    Nieuwlaat R; Vermeer F; Scholte op Reimer WJ; Boersma E; van 't Hof AW; Simoons ML
    Ned Tijdschr Geneeskd; 2004 Sep; 148(38):1878-82. PubMed ID: 15497784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hospital-wide vascular screening program at the University Medical Center, Utrecht: prevalence of risk factors and asymptomatic vascular disease from 1996 to 2002].
    Visseren FL; de Jaegere PP; Banga JD; Kappelle LJ; Eikelboom BC; Mali WP; Algra A; van der Graaf Y
    Ned Tijdschr Geneeskd; 2003 Nov; 147(48):2376-82. PubMed ID: 14677480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The 4th International Paris Symposium on Coronary Risk Factors. 22 May 1989. Proceedings].
    Ann Cardiol Angeiol (Paris); 1989 Dec; 38(9 Pt 2):577-601. PubMed ID: 2627103
    [No Abstract]   [Full Text] [Related]  

  • 5. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which lifestyle parameters discriminate high- from low-risk participants for coronary heart disease risk factors. Longitudinal analysis covering adolescence and young adulthood.
    Twisk JW; Kemper HC; van Mechelen W; Post GB
    J Cardiovasc Risk; 1997; 4(5-6):393-400. PubMed ID: 9865672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk factors for cardiovascular diseases in Turks in Amsterdam and in Ankara].
    Köycü B; Kara T; Camlidag O; Aydinli R; Verschuren WM; van Montfrans GA
    Ned Tijdschr Geneeskd; 1997 May; 141(18):882-8. PubMed ID: 9273453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public risk factor screening on the occasion of the ESC meeting in Amsterdam--results from "For Your Heart's Sake".
    Deckers JW; van Domburg R; Manger Cats V; Peters RJ
    Eur Heart J; 2001 Nov; 22(21):2025-6. PubMed ID: 11603910
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention and treatment of hypertension and coronary heart disease].
    Mendoza-González C; Rosas M; Estrada CL; Lorenzo JA; Méndez A; Martínez-Reding J; Martínez-Sánchez C; Pastelín G; Férez-Santander SM; Attie F
    Arch Cardiol Mex; 2008; 78 Suppl 2():S2-58-73. PubMed ID: 18938686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure reduction and coronary heart disease risk factor management: a conjoint approach. New York, New York, June 22, 1988. Proceedings.
    Am J Med; 1989 Jan; 86(1B):1-115. PubMed ID: 2913763
    [No Abstract]   [Full Text] [Related]  

  • 11. Decline of coronary heart disease mortality in The Netherlands from 1978 to 1985: contribution of medical care and changes over time in presence of major cardiovascular risk factors.
    Bots ML; Grobbee DE
    J Cardiovasc Risk; 1996 Jun; 3(3):271-6. PubMed ID: 8863098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classical risk factors and emerging elements in the risk profile for coronary artery disease.
    Gensini GF; Comeglio M; Colella A
    Eur Heart J; 1998 Feb; 19 Suppl A():A53-61. PubMed ID: 9519344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurogenic and psychological factors in coronary heart disease. Proceedings of the Sixth Paavo Nurmi Symposium, Porvoo, Finland, September 17-19, 1981.
    Acta Med Scand Suppl; 1982; 660():1-250. PubMed ID: 6958180
    [No Abstract]   [Full Text] [Related]  

  • 14. Silent myocardial ischemia. II. Pathophysiology, relation to risk factors, treatment.
    Velican C; Sipciu D
    Med Interne; 1989; 27(3):185-95. PubMed ID: 2694317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.
    Smith SC; Allen J; Blair SN; Bonow RO; Brass LM; Fonarow GC; Grundy SM; Hiratzka L; Jones D; Krumholz HM; Mosca L; Pasternak RC; Pearson T; Pfeffer MA; Taubert KA; ;
    Circulation; 2006 May; 113(19):2363-72. PubMed ID: 16702489
    [No Abstract]   [Full Text] [Related]  

  • 16. Coronary heart disease: hypertension and other risk factors. Proceedings of a satellite symposium of the first European Meeting on Hypertension.
    Am J Med; 1984 Feb; 76(2A):1-124. PubMed ID: 6702858
    [No Abstract]   [Full Text] [Related]  

  • 17. Selection of initial antihypertensive therapy: new perspectives on coronary heart disease. Risk factors provide new insights. Proceedings of a symposium. June 28-29, 1985, Oslo, Norway.
    Am J Med; 1986 Feb; 80(2A):1-125. PubMed ID: 3946454
    [No Abstract]   [Full Text] [Related]  

  • 18. [Restenosis after angioplasty].
    Bauters C; Van Belle E; McFadden E; Lablanche JM; Bertrand ME
    Arch Mal Coeur Vaiss; 1999 Nov; 92(11 Suppl):1579-82. PubMed ID: 10598238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of reclassifying moderate CKD as a coronary heart disease risk equivalent on the number of US adults recommended lipid-lowering treatment.
    Hyre AD; Fox CS; Astor BC; Cohen AJ; Muntner P
    Am J Kidney Dis; 2007 Jan; 49(1):37-45. PubMed ID: 17185144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of psychosocial factors in the pathogenesis of coronary heart disease. Proceedings of a conference held in Maastricht, March 15-17, 1979.
    Psychother Psychosom; 1980; 34(2-3):73-223. PubMed ID: 6111826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.